%20--%3e%3csvg%20width='63.297821mm'%20height='39.29665mm'%20viewBox='0%200%2063.297821%2039.29665'%20version='1.1'%20id='svg8765'%20inkscape:version='1.1%20(c4e8f9ed74,%202021-05-24)'%20sodipodi:docname='OBALogoSingle2.svg'%20xmlns:inkscape='http://www.inkscape.org/namespaces/inkscape'%20xmlns:sodipodi='http://sodipodi.sourceforge.net/DTD/sodipodi-0.dtd'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:svg='http://www.w3.org/2000/svg'%3e%3csodipodi:namedview%20id='namedview8767'%20pagecolor='%23ffffff'%20bordercolor='%23666666'%20borderopacity='1.0'%20inkscape:pageshadow='2'%20inkscape:pageopacity='0.0'%20inkscape:pagecheckerboard='0'%20inkscape:document-units='mm'%20showgrid='false'%20fit-margin-top='0'%20fit-margin-left='0'%20fit-margin-right='0'%20fit-margin-bottom='0'%20inkscape:zoom='1.1759259'%20inkscape:cx='179.85827'%20inkscape:cy='102.04724'%20inkscape:window-width='1920'%20inkscape:window-height='972'%20inkscape:window-x='0'%20inkscape:window-y='27'%20inkscape:window-maximized='1'%20inkscape:current-layer='layer1'%20/%3e%3cdefs%20id='defs8762'%20/%3e%3cg%20inkscape:label='Layer%201'%20inkscape:groupmode='layer'%20id='layer1'%20transform='translate(-31.351095,-50.101677)'%3e%3cpath%20style='fill:none;stroke:%233584e4;stroke-width:3.965;stroke-linecap:square;stroke-linejoin:round;stroke-miterlimit:4;stroke-dasharray:none;stroke-opacity:1'%20d='m%2077.07508,77.78787%2014.84134,8.87817%20V%2052.83397%20L%2034.08359,86.5521%20V%2053.69366%20l%2015.27351,9.31107'%20id='path8388'%20sodipodi:nodetypes='cccccc'%20/%3e%3c/g%3e%3c/svg%3e)
Market Performance
Stock returned +10.0% over the past year, broadly in line with market conditions.What is Nanologix Inc?
, a biotechnology company, provides diagnostics of viable microorganisms and viruses.
NNLX · Verdict
Moderate reward · high risk
NNLX stands out on volatility and valuation, but watch the cash flow signal.
Based on 88% data coverage
NNLX · Verdict
What’s working & what to watch
Strengths 2
- Volatility75/100
Above average
- Valuation67/100
Above average
Watchouts 3
- Cash flow6/100
-1959% free-cash-flow margin
- Profitability9/100
-3631% net margin · -214% ROE
- Balance sheet13/100
Current ratio 1.08
Model-based scoring. For information only — not financial advice.
What is Nanologix Inc?
, a biotechnology company, provides diagnostics of viable microorganisms and viruses. It offers rapid viral assay test, which is a method for detection and quantification of a virus; and N-assay diagnostics that furnish the ability to detect and identify bacteria and other microorganisms for pharmaceutical, industrial, veterinary, and environmental testing, as well as microbiology, soil microbiology and bioremediation, microbial physiology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity sectors. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 15.88K.
Financial Highlights
Investment Breakdown
Analysis
Reward: Moderate (49)The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.